HBV/HDV-IN-2

• UNSPSC Description:

  HBV/HDV-IN-2 (Compd 143) is a HBV, HDV and PD-1/PD-L1 inhibitor, with an EC50 of 35 nM for T cell activation[1].

• Target Antigen:

  HBV; PD-1/PD-L1

• Type:

  Reference compound

• Related Pathways:

  Anti-infection;Immunology/Inflammation

• Applications:

  COVID-19-anti-virus

• Field of Research:

  Cancer; Infection; Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/hbv-hdv-in-2.html

• Smiles:

  CC1=C(C=CC=C1NC(C2=CC(OC)=C(CN3CC[C@@H](O)C3)C=N2)=O)C4=NC=CC(C5=CC=C(CNC6CCN(C(C)=O)CC6)C(OC)=N5)=C4Cl

• Molecular Weight:

  714.25

• References & Citations:

  [1]Andrew G. Cole, et al. Substituted 1-arylaminocarbonyl-1'-heteroaryl compounds, substituted 1-heteroarylaminocarbonyl-1'-heteroaryl compounds and methods using same. Patent. WO2024069448A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  3034161-76-4